2024 Bipolar disorder Depression treatment 
Psychiatric Times
JULY 24, 2025
The depressive episode dates back 18 months, when she presented to her primary care physician (PCP) with depressed mood, anhedonia, decreased ability to concentrate and focus on daily home tasks, increasing hopelessness, and diminished energy and motivation to take on job responsibilities. 2024:81(12):1207-1214. JAMA Psychiatry.
Mad in America
MARCH 15, 2025
This turn to ketamine is occurring despite the fact that the Food and Drug Administration has repeatedly warned that the FDA has not approved ketamine for the treatment of any psychiatric disorder (though controversially approving esketamine nasal spray). Specifically, in 2024, internist and epidemiologist G.
Mad in America
JANUARY 4, 2025
American psychiatry has weathered the crisis; it will not have to confront a public stunned by news of how the oft-cited 67% cumulative remission rate, in the largest and longest study ever done to evaluate depression treatment,” was born of scientific misconduct.
Expert insights. Personalized for you.
Let's personalize your content